Zurn Elkay Water Solutions reported a 10.5% increase in revenue to $491 million and expects adjusted EBITDA to grow 14.9% year-over-year, excluding tariff refunds. The company recently acquired Intellihot, expanding its market by $1.1 billion and targeting demand in tankless water heaters driven by regulations. Despite solid operational performance and strategic expansion, Zurn Elkay trades at a premium compared to peers, leading analysts to maintain a Hold rating. This reflects confidence in growth but caution due to stretched valuation metrics.
Zurn Elkay Water Solutions is the subject of this report. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Oct 06, 2026 18:13 WIB: 65 of 93 priced US Industrials-sector stocks rose while 22 fell. Notable movers include RDW at USD 10.59 with 84% buy orders, AMSC at USD 30.40 with 100% buy orders, and SYM at USD 43.44 with 89% buy orders.
Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...
The Bitcoin Bull Score, an index by CryptoQuant measuring market bullishness, reached 90 out of 100 on September 29, 2026, indicating a strong but not peak bullish phase. Despite this high score, spot demand for Bitcoin has declined by 170,000 BTC ov...
Rocket One Inc. has signed a 12-month patent license agreement with the U.S. Department of the Air Force to evaluate a patented technology designed to capture hostile drones and isolate their communications. This technology combines physical containm...
Citi has named NatWest Group as one of its top picks in the European banking sector, citing steady loan growth and supportive interest rates as key factors. Despite softer deposit growth and margin pressure from shifts to higher-yield term deposits, ...
NextPlat Corp has completed the acquisition of an independent pharmacy near Pensacola, Florida, for $1.49 million. The pharmacy, which generated $5.6 million in sales in 2025 and operates debt-free, will enhance NextPlat's PharmcoRx segment by expand...
